Abstract:Vascular aging plays a central role in health problems and mortality in older people. Apart from the impact of several classical cardiovascular risk factors on the vasculature, chronological aging remains the single most important determinant of cardiovascular problems. The causative mechanisms by which chronological aging mediates its impact, independently from classical risk factors, remain to be elucidated. In recent years evidence has accumulated that unrepaired DNA damage may play an important role. Observations in animal models and in humans indicate that under conditions during which DNA damage accumulates in an accelerated rate, functional decline of the vasculature takes place in a similar but more rapid or more exaggerated way than occurs in the absence of such conditions. Also epidemiological studies suggest a relationship between DNA maintenance and age-related cardiovascular disease. Accordingly, mouse models of defective DNA repair are means to study the mechanisms involved in biological aging of the vasculature. We here review the evidence of the role of DNA damage in vascular aging, and present mechanisms by which genomic instability interferes with regulation of the vascular tone. In addition, we present potential remedies against vascular aging induced by genomic instability. Central to this review is the role of diverse types of DNA damage (telomeric, non-telomeric and mitochondrial), of cellular changes (apoptosis, senescence, autophagy), mediators of senescence and cell growth (plasminogen activator inhibitor-1 (PAI-1), cyclin-dependent kinase inhibitors, senescence-associated secretory phenotype (SASP)/senescence-messaging secretome (SMS), insulin and insulin-like growth factor 1 (IGF-1) signaling), the adenosine monophosphate-activated protein kinase (AMPK)-mammalian target of rapamycin (mTOR)-nuclear factor kappa B (NFκB) axis, reactive oxygen species (ROS) vs. endothelial nitric oxide synthase (eNOS)-cyclic guanosine monophosphate (cGMP) signaling, phosphodiesterase (PDE) 1 and 5, transcription factor NF-E2-related factor-2 (Nrf2), and diet restriction.

Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Mitochondria and oxidative stress in heart aging

Role of mitochondria in oxidative stress and aging

Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases

Mitochondrial ROS-Modulated mtDNA: A Potential Target for Cardiac Aging

Mitochondria: Aging, Metabolic Syndrome and Cardiovascular Diseases. Formation of a New Paradigm

Oxidative Stress, Mitochondrial DNA Mutation, and Impairment of Antioxidant Enzymes in Aging 1

New insights into vascular aging: Emerging role of mitochondria function

Aging Hallmarks and the Role of Oxidative Stress

DNA Damage: A Main Determinant of Vascular Aging

The Role of Oxidative Stress in the Aging Heart

Mitochondrial Aging and Age-Related Dysfunction of Mitochondria

The Role of Mitochondrial Dysfunction in Vascular Disease, Tumorigenesis, and Diabetes

The Mitochondrial Production of Reactive Oxygen Species in Relation to Aging and Pathology

The Role of Oxidative Stress and Inflammation in Cardiovascular Aging

Mitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging

Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue

Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases

Molecular insights into mitoepigenetic stress response signaling in age-associated cardiovascular disease risk

Oxidative damage to mitochondrial DNA and its relationship to ageing